Phibro Animal Health | PAHC - Debt


Phibro Animal Health reported $474.17M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Align Technology USD 116.04M 1.6M Mar/2026
ANI Pharmaceuticals USD 617.04M 3.28M Dec/2025
Aurora Cannabis CAD 23.86M 76.48M Mar/2026
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Canopy Growth CAD 278.71M 19.38M Mar/2026
Corcept Therapeutics USD 9.64M 3.53M Mar/2026
Eli Lilly USD 42.5B 3.6M Dec/2025
Henry Schein USD 3.75B 313M Mar/2026
Idexx Laboratories USD 1.11B 129.39M Mar/2026
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Merck USD 49.34B 7.97B Dec/2025
Nektar Therapeutics USD 0 0 Jun/2022
Pacira USD 367.66M 4.53M Mar/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.08B 38.27M Dec/2025
Supernus Pharmaceuticals USD 40.98M 1.23M Dec/2025
Zoetis USD 9.24B 1.96B Dec/2025